Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interaction of Saracatinib with Alcohol in Social Drinkers
NCT02732587Phase 1Completed
- Sponsor
- Yale University
- Start
- Nov 2015
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of saracatinib in alcohol dependence, sponsored by Yale University. Primary endpoint: Safety/Tolerability of Study Medication at 8 days. Started Nov 2015; status: completed.
02
Drugs
saracatinib
03
Conditions
alcohol dependence
Beyond the preview
Go deeper on NCT02732587.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02732587.